News and Views

Nurse Well-Being

If You’re Trying to Be Productive, Stop Multitasking

When it comes to the human brain, the ability to effectively multitask is a myth. Although computers can run two or more programs simultaneously, our brains must task-switch, and in the transfer of attention, time and productivity are lost. Monotasking, or single tasking, is now considered a way to increase productivity and actually maximize time.

Trending Topics

View All Topics

Antihistamines May Improve Survival From Malignant Melanoma

Antihistamines May Improve Survival From Malignant Melanoma

Oncology Drug Reference Sheet: Enfortumab Vedotin-Ejfv

U.S. Food and Drug Administration (FDA)

Oncology Drug Reference Sheet: Enfortumab Vedotin-Ejfv

$FDA Approves Brexucabtagene Autoleucel for Relapsed or Refractory MCL$

U.S. Food and Drug Administration (FDA)

FDA Approves Brexucabtagene Autoleucel for Relapsed or Refractory MCL

Bertie A. Field, RN, MS

Meet Your ONS Leader: Bertie A. Field, RN, MS

Insulin Resistance May Explain Racial Disparity in Breast Cancer

Cancer Research

Insulin Resistance May Explain Racial Disparity in Breast Cancer

The Case of the HPV-Positive Perk

Clinical Practice

The Case of the HPV-Positive Perk

Ryan Conover, ONS director of information services

ONS Director Named Finalist for Pittsburgh’s CIO of the Year

What the Evidence Says for Use of Quigong in Patients With Cancer

Symptom Management

What the Evidence Says About Qigong in Patients With Cancer

The Case of the Thyroid Tradeoff

Clinical Practice

The Case of the Thyroid Tradeoff

Opioid-Related Death Rates Are Increasing, But Less So in Cancer Survivors

Opioid-Related Death Rates Are Increasing, But Less So in Cancer Survivors

Telehealth Boom Opens New Roles for Oncology Nursing

Oncology Nursing Roles

Telehealth Boom Opens New Roles for Oncology Nursing

Managing Cancer-Related PTSD Starts With Acknowledgement

Patient Empowerment

Managing Cancer-Related PTSD Starts With Acknowledgement

Pediatric Cancer Survivors Require Additional Care and Monitoring

Pediatric Cancer Survivors Require Additional Care and Monitoring

ONS Offers Companies the Oncology Nursing Society Seal of Approval™ to promote Oncology Nurse and Patient Support Materials

ONS Offers Companies the Oncology Nursing Society Seal of Approval™ to promote Oncology Nurse and Patient Support Materials

ONS Board Addresses Members About Racism and Disparities in Cancer Care

ONS Board Addresses Members About Racism and Disparities in Cancer Care

Myeloproliferative Neoplasm Symptoms, Diagnosis, Treatment, and Survivorship Recommendations

Myeloproliferative Neoplasm Symptoms, Diagnosis, Treatment, and Survivorship Recommendations

FDA Approves Oral Combination of Decitabine and Cedazuridine for Myelodysplastic Syndromes

U.S. Food and Drug Administration (FDA)

FDA Approves Oral Combination of Decitabine and Cedazuridine for Myelodysplastic Syndromes

Prostate Cancer Clinical Trials Don’t Reflect Racial Diversity—And It’s Getting Worse Over Time

Cancer Research

Prostate Cancer Clinical Trials Don’t Reflect Racial Diversity—And It’s Getting Worse Over Time

Secondary Cancers in Pediatric Survivors

Secondary Cancers in Pediatric Survivors

How to Approach Medical Device Failures

Oncology Nurse Education

When Function Becomes Malfunction

Variants of Unknown Significance

Genetics & Genomics

Help Patients Understand Genomic Variants of Unknown Significance

All Politics Is Local, and That’s Why You Should Get Involved in ONS Advocacy

Cancer Healthcare Advocacy

All Politics Is Local, and That’s Why You Should Get Involved in ONS Advocacy

FDA Approves Avelumab for Urothelial Carcinoma Maintenance Treatment

Oncology Drug Research

FDA Approves Avelumab for Urothelial Carcinoma Maintenance Treatment

Mental Well-Being Is a Focus of Primary Care Throughout Survivorship

Mental Well-Being Is a Focus of Primary Care Throughout Survivorship

Antibody-Drug Conjugates Join the Best of Two Worlds Into One New Treatment

Cancer Research

Antibody-Drug Conjugates Join the Best of Two Worlds Into One New Treatment

FDA Approves Pembrolizumab for First-Line Treatment of MSI-H/dMMR Colorectal Cancer

U.S. Food and Drug Administration (FDA)

FDA Approves Pembrolizumab for First-Line Treatment of MSI-H/dMMR Colorectal Cancer

FDA Approves Combination of Pertuzumab, Trastuzumab, and Hyaluronidase-Zzxf for HER2-Positive Breast Cancer

Oncology Drug Research

FDA Approves Combination of Pertuzumab, Trastuzumab, and Hyaluronidase-Zzxf for HER2-Positive Breast Cancer

Develop Your Individual Cancer Screening Plan

Cancer Screening

Develop Your Individual Cancer Screening Plan

FDA Approves Pembrolizumab for Treatment of Cutaneous Squamous Cell Carcinoma

Oncology Drug Research

FDA Approves Pembrolizumab for Treatment of Cutaneous Squamous Cell Carcinoma

How to Practice Self-Care During Times of Uncertainty

Nurse Well-Being

How to Practice Self-Care During Times of Uncertainty

Cancer Consortium Report Reveals High Mortality Rates in Patients With COVID-19 and Cancer

Cancer Consortium Report Reveals High Mortality Rates in Patients With COVID-19 and Cancer

Nurses Can Provide Safe Spaces for LGBTQ Patients With Cancer

Patient Advocacy

Nurses Can Provide Safe Spaces for LGBTQ Patients With Cancer

$FDA Approves Selinexor for Relapsed or Refractory Diffuse Large B-Cell Lymphoma$

Oncology Drug Research

FDA Approves Selinexor for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

HIV-Positive Patients With Cancer Need to Be Included in Clinical Drug Trials

U.S. Food and Drug Administration (FDA)

HIV-Positive Patients With Cancer Need to Be Included in Clinical Drug Trials

Meet Your ONS Leader: Kristin Ferguson, DNP, RN, OCN®

Meet Your ONS Leader: Kristin Ferguson, DNP, RN, OCN®

FDA Grants Accelerated Approval to Tazemetostat for Follicular Lymphoma

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Tazemetostat for Follicular Lymphoma

Polypharmacy Before Cancer Is Predictive of Post-Treatment Hospitalization

Polypharmacy Before Cancer Is Predictive of Post-Treatment Hospitalization

FDA Approves Pembrolizumab for Patients With TMB-H Solid Tumors

U.S. Food and Drug Administration (FDA)

FDA Approves Pembrolizumab for Patients With TMB-H Solid Tumors

Misconceptions About Radioactive Targeted Therapies

Genetics & Genomics

An Oncology Nurse’s Primer on Genomics and Biomarker Terminology

Exercise Before ADT Treatment Reduces Rate of Side Effects

Cancer Research

Exercise Before ADT Treatment Reduces Rate of Side Effects

FDA Extends Indication for Gemtuzumab Ozogamicin for CD33-Positive AML in Pediatric Patients

U.S. Food and Drug Administration (FDA)

FDA Extends Indication for Gemtuzumab Ozogamicin for CD33-Positive AML in Pediatric Patients

FDA Grants Accelerated Approval to Lurbinectedin for Metastatic Small Cell Lung Cancer

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Lurbinectedin for Metastatic Small Cell Lung Cancer

FDA Approves Nivolumab for Esophageal Squamous Cell Carcinoma

U.S. Food and Drug Administration (FDA)

FDA Approves Nivolumab for Esophageal Squamous Cell Carcinoma

ONS Virtual Conference Bridges the Gap Between Education and Practice Change

ONS Virtual Conference Bridges the Gap Between Education and Practice Change

Pelvic Radiation May Decrease Bone Mineral Density

Radiation Therapy

Pelvic Radiation May Decrease Bone Mineral Density

Manage Late Effects From HPV-Positive Oropharyngeal Cancers

Treatment Side Effects

Manage Late Effects From HPV-Positive Oropharyngeal Cancers

Multiple Myeloma Prevention, Screening, Treatment, and Survivorship Recommendations

Clinical Practice

Multiple Myeloma Prevention, Screening, Treatment, and Survivorship Recommendations

For 2021, ONS Election Recruitment Goes Virtual, Congress Fees Remain Level

For 2021, ONS Election Recruitment Goes Virtual, Congress Fees Remain Level

E-Cigarettes Linked to Bladder Cancer Carcinogens

Cancer Research

E-Cigarettes Linked to Bladder Cancer Carcinogens

Back to Top ▲